医薬品有効成分(API)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Active Pharmaceutical Ingredient (API) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8100026)・商品コード:GIR8100026
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月22日(※2024年版があります。お問い合わせください)
・ページ数:128
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、医薬品有効成分(API)の世界市場について調べ、まとめました。種類別セグメントは、革新的APISセグメント、汎用APISセグメント等、用途別セグメントは、腫瘍学、糖尿病、循環器疾患、CNSおよび神経疾患、整形外科疾患、その他等に区分しました。医薬品有効成分(API)の世界市場概観、メーカー動向、メーカー別医薬品有効成分(API)シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・医薬品有効成分(API)の市場概観
・医薬品有効成分(API)のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・医薬品有効成分(API)のメーカー別販売動向、市場シェア、市場集中度、競争動向
・医薬品有効成分(API)の世界市場規模
・医薬品有効成分(API)の北米市場分析(アメリカ、カナダ、メキシコ等)
・医薬品有効成分(API)のアメリカ市場規模推移
・医薬品有効成分(API)のカナダ市場規模推移
・医薬品有効成分(API)のメキシコ市場規模推移
・医薬品有効成分(API)のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・医薬品有効成分(API)のドイツ市場規模推移
・医薬品有効成分(API)のイギリス市場規模推移
・医薬品有効成分(API)のロシア市場規模推移
・医薬品有効成分(API)のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・医薬品有効成分(API)の日本市場規模推移
・医薬品有効成分(API)の中国市場規模推移
・医薬品有効成分(API)の韓国市場規模推移
・医薬品有効成分(API)のインド市場規模推移
・医薬品有効成分(API)の東南アジア市場規模推移
・医薬品有効成分(API)の南米市場分析(ブラジル、アルゼンチン等)
・医薬品有効成分(API)の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・医薬品有効成分(API)の種類別分析/市場規模推移(革新的APISセグメント、汎用APISセグメント)
・医薬品有効成分(API)の用途別分析/市場規模推移(腫瘍学、糖尿病、循環器疾患、CNSおよび神経疾患、整形外科疾患、その他)
・医薬品有効成分(API)の市場予測(地域別予測、種類別予測、用途別予測)
・医薬品有効成分(API)の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.

Scope of the Report:

This report studies the Active Pharmaceutical Ingredient (API) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Active Pharmaceutical Ingredient (API) market by product type and applications/end industries.

The global Active Pharmaceutical Ingredient (API) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Active Pharmaceutical Ingredient (API).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Teva

Sun Pharmaceutical

Aurobindo Pharma

Albemarle

Sigma-Aldrich

Mylan

Allergan

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Innovative APIS Segment

Generic APIS Segment

Market Segment by Applications, can be divided into

Oncology

Diabetes

Cardiovascular Disease

Cns and Neurological Disorders

Orthopedic Disorders

Nephrology

Ophthalmology

Pulmonology

Gastrointestinal Disorders

【レポートの目次】

Table of Contents

1 Active Pharmaceutical Ingredient (API) Market Overview

1.1 Product Overview and Scope of Active Pharmaceutical Ingredient (API)

1.2 Classification of Active Pharmaceutical Ingredient (API) by Types

1.2.1 Global Active Pharmaceutical Ingredient (API) Revenue Comparison by Types (2017-2023)

1.2.2 Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Types in 2017

1.2.3 Innovative APIS Segment

1.2.4 Generic APIS Segment

1.3 Global Active Pharmaceutical Ingredient (API) Market by Application

1.3.1 Global Active Pharmaceutical Ingredient (API) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Oncology

1.3.3 Diabetes

1.3.4 Cardiovascular Disease

1.3.5 Cns and Neurological Disorders

1.3.6 Orthopedic Disorders

1.3.7 Nephrology

1.3.8 Ophthalmology

1.3.9 Pulmonology

1.3.10 Gastrointestinal Disorders

1.4 Global Active Pharmaceutical Ingredient (API) Market by Regions

1.4.1 Global Active Pharmaceutical Ingredient (API) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Active Pharmaceutical Ingredient (API) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Active Pharmaceutical Ingredient (API) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Active Pharmaceutical Ingredient (API) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Active Pharmaceutical Ingredient (API) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Active Pharmaceutical Ingredient (API) Status and Prospect (2013-2023)

1.5 Global Market Size of Active Pharmaceutical Ingredient (API) (2013-2023)

2 Manufacturers Profiles

2.1 Teva

2.1.1 Business Overview

2.1.2 Active Pharmaceutical Ingredient (API) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Teva Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sun Pharmaceutical

2.2.1 Business Overview

2.2.2 Active Pharmaceutical Ingredient (API) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Aurobindo Pharma

2.3.1 Business Overview

2.3.2 Active Pharmaceutical Ingredient (API) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Albemarle

2.4.1 Business Overview

2.4.2 Active Pharmaceutical Ingredient (API) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Albemarle Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Sigma-Aldrich

2.5.1 Business Overview

2.5.2 Active Pharmaceutical Ingredient (API) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sigma-Aldrich Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Mylan

2.6.1 Business Overview

2.6.2 Active Pharmaceutical Ingredient (API) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Mylan Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

2.7 Allergan

2.7.1 Business Overview

2.7.2 Active Pharmaceutical Ingredient (API) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Allergan Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Active Pharmaceutical Ingredient (API) Market Competition, by Players

3.1 Global Active Pharmaceutical Ingredient (API) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Active Pharmaceutical Ingredient (API) Players Market Share

3.2.2 Top 10 Active Pharmaceutical Ingredient (API) Players Market Share

3.3 Market Competition Trend

4 Global Active Pharmaceutical Ingredient (API) Market Size by Regions

4.1 Global Active Pharmaceutical Ingredient (API) Revenue and Market Share by Regions

4.2 North America Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

4.3 Europe Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

4.5 South America Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

5 North America Active Pharmaceutical Ingredient (API) Revenue by Countries

5.1 North America Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)

5.2 USA Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

5.3 Canada Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

5.4 Mexico Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

6 Europe Active Pharmaceutical Ingredient (API) Revenue by Countries

6.1 Europe Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)

6.2 Germany Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

6.3 UK Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

6.4 France Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

6.5 Russia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

6.6 Italy Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue by Countries

7.1 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)

7.2 China Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

7.3 Japan Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

7.4 Korea Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

7.5 India Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

8 South America Active Pharmaceutical Ingredient (API) Revenue by Countries

8.1 South America Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)

8.2 Brazil Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

8.3 Argentina Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

8.4 Colombia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Active Pharmaceutical Ingredient (API) by Countries

9.1 Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

9.3 UAE Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

9.4 Egypt Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

9.6 South Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

10 Global Active Pharmaceutical Ingredient (API) Market Segment by Type

10.1 Global Active Pharmaceutical Ingredient (API) Revenue and Market Share by Type (2013-2018)

10.2 Global Active Pharmaceutical Ingredient (API) Market Forecast by Type (2018-2023)

10.3 Innovative APIS Segment Revenue Growth Rate (2013-2023)

10.4 Generic APIS Segment Revenue Growth Rate (2013-2023)

11 Global Active Pharmaceutical Ingredient (API) Market Segment by Application

11.1 Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2013-2018)

11.2 Active Pharmaceutical Ingredient (API) Market Forecast by Application (2018-2023)

11.3 Oncology Revenue Growth (2013-2018)

11.4 Diabetes Revenue Growth (2013-2018)

11.5 Cardiovascular Disease Revenue Growth (2013-2018)

11.6 Cns and Neurological Disorders Revenue Growth (2013-2018)

11.7 Orthopedic Disorders Revenue Growth (2013-2018)

11.8 Nephrology Revenue Growth (2013-2018)

11.9 Ophthalmology Revenue Growth (2013-2018)

11.10 Pulmonology Revenue Growth (2013-2018)

11.11 Gastrointestinal Disorders Revenue Growth (2013-2018)

12 Global Active Pharmaceutical Ingredient (API) Market Size Forecast (2018-2023)

12.1 Global Active Pharmaceutical Ingredient (API) Market Size Forecast (2018-2023)

12.2 Global Active Pharmaceutical Ingredient (API) Market Forecast by Regions (2018-2023)

12.3 North America Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)

12.4 Europe Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)

12.6 South America Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Active Pharmaceutical Ingredient (API) Picture

Table Product Specifications of Active Pharmaceutical Ingredient (API)

Table Global Active Pharmaceutical Ingredient (API) and Revenue (Million USD) Market Split by Product Type

Figure Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Types in 2017

Figure Innovative APIS Segment Picture

Figure Generic APIS Segment Picture

Table Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Application (2013-2023)

Figure Active Pharmaceutical Ingredient (API) Revenue Market Share by Applications in 2017

Figure Oncology Picture

Figure Diabetes Picture

Figure Cardiovascular Disease Picture

Figure Cns and Neurological Disorders Picture

Figure Orthopedic Disorders Picture

Figure Nephrology Picture

Figure Ophthalmology Picture

Figure Pulmonology Picture

Figure Gastrointestinal Disorders Picture

Table Global Market Active Pharmaceutical Ingredient (API) Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (2013-2023)

Table Teva Basic Information, Manufacturing Base and Competitors

Table Teva Active Pharmaceutical Ingredient (API) Type and Applications

Table Teva Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Type and Applications

Table Sun Pharmaceutical Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors

Table Aurobindo Pharma Active Pharmaceutical Ingredient (API) Type and Applications

Table Aurobindo Pharma Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

Table Albemarle Basic Information, Manufacturing Base and Competitors

Table Albemarle Active Pharmaceutical Ingredient (API) Type and Applications

Table Albemarle Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

Table Sigma-Aldrich Basic Information, Manufacturing Base and Competitors

Table Sigma-Aldrich Active Pharmaceutical Ingredient (API) Type and Applications

Table Sigma-Aldrich Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Active Pharmaceutical Ingredient (API) Type and Applications

Table Mylan Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Active Pharmaceutical Ingredient (API) Type and Applications

Table Allergan Active Pharmaceutical Ingredient (API) Revenue, Gross Margin and Market Share (2016-2017)

Table Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Players (2013-2018)

Table Global Active Pharmaceutical Ingredient (API) Revenue Share by Players (2013-2018)

Figure Global Active Pharmaceutical Ingredient (API) Revenue Share by Players in 2016

Figure Global Active Pharmaceutical Ingredient (API) Revenue Share by Players in 2017

Figure Global Top 5 Players Active Pharmaceutical Ingredient (API) Revenue Market Share in 2017

Figure Global Top 10 Players Active Pharmaceutical Ingredient (API) Revenue Market Share in 2017

Figure Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Regions (2013-2018)

Table Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Regions (2013-2018)

Figure Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Regions (2013-2018)

Figure Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Regions in 2017

Figure North America Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Europe Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure South America Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Table North America Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)

Table North America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2013-2018)

Figure North America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2013-2018)

Figure North America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries in 2017

Figure USA Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Canada Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Mexico Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Table Europe Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Countries (2013-2018)

Figure Europe Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2013-2018)

Figure Europe Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries in 2017

Figure Germany Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure UK Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure France Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Russia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Italy Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries in 2017

Figure China Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Japan Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Korea Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure India Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Table South America Active Pharmaceutical Ingredient (API) Revenue by Countries (2013-2018)

Table South America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2013-2018)

Figure South America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2013-2018)

Figure South America Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries in 2017

Figure Brazil Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Argentina Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Colombia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure UAE Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Egypt Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure Nigeria Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Figure South Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2013-2018)

Table Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) by Type (2013-2018)

Table Global Active Pharmaceutical Ingredient (API) Revenue Share by Type (2013-2018)

Figure Global Active Pharmaceutical Ingredient (API) Revenue Share by Type (2013-2018)

Figure Global Active Pharmaceutical Ingredient (API) Revenue Share by Type in 2017

Table Global Active Pharmaceutical Ingredient (API) Revenue Forecast by Type (2018-2023)

Figure Global Active Pharmaceutical Ingredient (API) Market Share Forecast by Type (2018-2023)

Figure Global Innovative APIS Segment Revenue Growth Rate (2013-2018)

Figure Global Generic APIS Segment Revenue Growth Rate (2013-2018)

Table Global Active Pharmaceutical Ingredient (API) Revenue by Application (2013-2018)

Table Global Active Pharmaceutical Ingredient (API) Revenue Share by Application (2013-2018)

Figure Global Active Pharmaceutical Ingredient (API) Revenue Share by Application (2013-2018)

Figure Global Active Pharmaceutical Ingredient (API) Revenue Share by Application in 2017

Table Global Active Pharmaceutical Ingredient (API) Revenue Forecast by Application (2018-2023)

Figure Global Active Pharmaceutical Ingredient (API) Market Share Forecast by Application (2018-2023)

Figure Global Oncology Revenue Growth Rate (2013-2018)

Figure Global Diabetes Revenue Growth Rate (2013-2018)

Figure Global Cardiovascular Disease Revenue Growth Rate (2013-2018)

Figure Global Cns and Neurological Disorders Revenue Growth Rate (2013-2018)

Figure Global Orthopedic Disorders Revenue Growth Rate (2013-2018)

Figure Global Nephrology Revenue Growth Rate (2013-2018)

Figure Global Ophthalmology Revenue Growth Rate (2013-2018)

Figure Global Pulmonology Revenue Growth Rate (2013-2018)

Figure Global Gastrointestinal Disorders Revenue Growth Rate (2013-2018)

Figure Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Active Pharmaceutical Ingredient (API) Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)

Figure Europe Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)

Figure South America Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue Market Forecast (2018-2023)



【掲載企業】

Teva、Sun Pharmaceutical、Aurobindo Pharma、Albemarle、Sigma-Aldrich、Mylan、Allergan

【レポートのキーワード】

医薬品有効成分(API)、革新的APISセグメント、汎用APISセグメント、腫瘍学、糖尿病、循環器疾患、CNSおよび神経疾患、整形外科疾患、その他

★調査レポート[医薬品有効成分(API)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8100026)販売に関する免責事項を必ずご確認ください。
★調査レポート[医薬品有効成分(API)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆